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CD8+ T cells and NK cells protect from viral infections
by killing virally infected cells and secreting inter-
feron-g. Several inhibitory receptors limit the magni-
tude and duration of these anti-viral responses.
NKG2A, which is encoded by Klrc1, is a lectin-like
inhibitory receptor that is expressed as a hetero-
dimer with CD94 on NK cells and activated CD8+
T cells. Previous studies on the impact of CD94/
NKG2A heterodimers on anti-viral responses have
yielded contrasting results and the in vivo function
of NKG2A remains unclear. Here, we generated
Klrc1–/– mice and found that NKG2A is selectively
required for resistance to ectromelia virus (ECTV).
NKG2A functions intrinsically within ECTV-specific
CD8+ T cells to limit excessive activation, prevent
apoptosis, and preserve the specific CD8+ T cell
response. Thus, although inhibitory receptors often
cause T cell exhaustion and viral spreading during
chronic viral infections, NKG2A optimizes CD8+
T cell responses during an acute poxvirus infection.
INTRODUCTION
CD8+ T cells and NK cells contribute to host defense against viral
infections by killing virally infected cells and secreting interferon-
g (IFN-g) (Biron, 2010). Both CD8+ T cells and NK cells are equip-
ped with multiple inhibitory receptors that control the magnitude
and duration of cytotoxic lymphocyte responses (Odorizzi and
Wherry, 2012). These receptors can instigate disparate impacts
on anti-viral responses. When cognate ligands are expressed on
infected cells, inhibitory receptors control the release of lytic me-
diators and IFN-g. This processmight reduce tissue damage and1112 Immunity 43, 1112–1124, December 15, 2015 ª2015 Elsevier Inimmunopathology during acute infections (Frebel et al., 2012;
Rygiel et al., 2009) but can facilitate T cell exhaustion and viral
replication during chronic viral infections (Odorizzi and Wherry,
2012). Some viruses encode ligands that engage NK cell and
CD8+T cell inhibitory receptors to impede killing of virally infected
cells and facilitate viral replication (Lanier, 2008). When cognate
ligands are expressed on dendritic cells (DCs) or T cells, inhibi-
tory receptors might prevent NK-cell-mediated lysis of DCs or
T cells that participate in the adaptive immune response (Lu
et al., 2007; Waggoner et al., 2010, 2012; Xu et al., 2014). In
this case, inhibitory receptors might accelerate the clearance of
virally infected cells but also promote excessive adaptive re-
sponses, causing tissue damage and immunopathology.
NKG2A is an inhibitory receptor expressed on a subset of NK
cells and activated CD8+ T cells. It belongs to a family of lectin-
like cell receptors that comprise three distinct isoforms, NKG2A
(encoded byKlrc1), NKG2C (encoded byKlrc2), and NKG2E (en-
coded by Klrc3), collectively called NKG2X. NKG2A pairs with
CD94 (encoded by Klrd1) to form a heterodimer that binds the
non-classical class I molecule Qa-1 in mice (Vance et al., 1998;
Zeng et al., 2012) and human leukocyte antigen E (HLA-E) in hu-
mans (Braud et al., 1998; Lee et al., 1998; Sullivan et al., 2007).
The dominant peptide bound to Qa-1, named Qdm, is derived
from the leader sequences of mouse major histocompatibility
complex (MHC) class I molecules H-2D and H-2L (Aldrich
et al., 1994; Zeng et al., 2012). NKG2A transmits intracellular
inhibitory signals by recruiting the protein tyrosine phosphatases
SHP1 and SHP2 (Kabat et al., 2002; Le Dre´an et al., 1998).
NKG2C and NKG2E also pair with CD94 to bind Qa-1 (Vance
et al., 1999). However, NKG2C and NKG2E transmit activating
signals through the transmembrane adaptor DAP12, which re-
cruits the protein tyrosine kinases Syk and ZAP70 (Taylor
et al., 2000). Whereas NKG2C and NKG2E directly bind DAP12
through a salt bridge in their transmembrane domains in humans
(Call et al., 2010), NKG2C and NKG2E associate with DAP12
indirectly in mice, because murine CD94 forms a salt bridge
with DAP12 in its transmembrane region (Saether et al., 2011).c.
Previous investigations of CD94/NKG2A heterodimer func-
tion during viral infections using blocking antibodies or Qa-1-
deficient mice have yielded contrasting results. CD94/NKG2A
heterodimers inhibited CD8+ T cell cytotoxic responses to pol-
yoma virus (Moser et al., 2002) and inhibited NK-cell-mediated
killing of cells infected with human cytomegalovirus (HCMV)
(Tomasec et al., 2000). In contrast, CD94/NKG2A heterodimers
did not inhibit CD8+ T cell effector functions during lymphocytic
choriomeningitis virus (LCMV) or Listeria monocytogenes (Lm)
infections (McMahon et al., 2002; Miller et al., 2002). Another
report suggested that CD94/NKG2X complexes might protect
both NK and T cells from apoptosis during Lm infection (Gun-
turi et al., 2003). More recently, it was shown that CD94-defi-
cient (Klrd1–/–) mice are highly susceptible to mouse orthopox-
virus ectromelia virus (ECTV) infection (Fang et al., 2011).
However, susceptibility to infection was not attributed to lack
of CD94/NKG2A heterodimers, but rather to loss of the acti-
vating CD94/NKG2E/DAP12 complex, which possibly triggered
lysis of ECTV-infected cells through recognition of a viral pep-
tide bound to Qa-1. Finally, Klrc1–/– mice had more immunopa-
thology during influenza and adenovirus infections (Ely et al.,
2014).
To unequivocally determine the function of NKG2A during viral
infections in vivo, we generated Klrc1–/– mice on the C56BL/6
background and tested immune responses against LCMV,
VSV, vaccinia virus (VV), and ECTV. We found that Klrc1–/–
mice are uniquely susceptible to infection by ECTV and that
NKG2A is required to sustain virus-specific CD8+ T cells by pre-
venting activation-induced cell death (AICD).
RESULTS
Mouse NK Cells Lack Surface Expression of NKG2C and
NKG2E
To generate Klrc1–/– mice, we targeted exons 1 through 4 of
Klrc1 (Figure S1A). We confirmed that mouse splenocytes lack
Klrc1 transcripts but maintain transcription of Klrc2 and Klrc3
(Figure S1B), indicating that the deletion is limited to Klrc1. NK,
NKT, and T cells from spleens, livers, and lungs were present
at similar frequencies in Klrc1–/– and WT control mice (Fig-
ure S1C). NK cells from Klrc1–/– mice were mature, as judged
by CD11b and CD27 expression. Thus, NKG2A plays no obvious
role in the development of NK or T cells. Splenic NK cells also
expressed normal amounts of KLRG1, CD49b, Ly49 family
members, and NKG2D (Figure S1D), indicating that the receptor
repertoire is undisturbed by the NKG2A deletion. These results
are consistent with previous studies on DBA/2J mice, which
are naturally deficient for CD94, yet exhibit no developmental
defects (Vance et al., 2002).
To verify that NKG2A expression was completely ablated
in Klrc1–/– mice, we assessed cell surface expression by flow
cytometry with an antibody that recognizes all three mouse
NKG2X family members. Approximately 40% of WT splenic NK
cells expressed NKG2X on the surface under steady-state con-
ditions. Notably, NK cells from Klrc1–/– spleens completely
lacked NKG2X surface expression (Figure 1A), suggesting that
NKG2A is the only NKG2X family member expressed on the sur-
face of mouse NK cells. Because NKG2E has been implicated in
the control of ECTV (Fang et al., 2011), we monitored NKG2XImmexpression on NK cells after ECTV infection. However, NK cells
from Klrc1–/– spleens completely lacked NKG2X surface expres-
sion even after infection. We next assessed NKG2X expression
on T cells. Only a small population of naive WT CD8+ T cells
was positive for NKG2X expression. CD8+ T cells from Klrc1–/–
spleens also expressed little to no NKG2X under homeostatic
conditions. After infection with ECTV, approximately one-quarter
of WT CD8+ T cells were NKG2X+, whereas only 0.4% of Klrc1–/–
CD8+ T cells were NKG2X+ (Figure 1B). We corroborated these
observations by staining NK cells and activated CD8+ T cells
with both anti-NKG2ACE and an antibody specific for NKG2AB6.
Both antibodies stained each WT population equivalently and
did not mark any cells from Klrc1–/– samples (Figure S1E). These
data are in agreement with previous studies showing that
NKG2A comprises almost all of the NKG2X molecules found
on mouse NK cells and activated CD8+ T cells (Kawamura
et al., 2009; Vance et al., 2002).
CD94 Is Surface Expressed with DAP12 in the Absence
of NKG2X
Analysis of CD94 expression confirmed lack of detectable
NKG2C or NKG2E associated with CD94. WT NK cells from un-
infected and ECTV-infected mice showed two peaks of CD94
expression; the higher peak corresponded to CD94/NKG2X
complexes, whereas the lower peak lacked NKG2X (Figure 1C,
top, and 1A). The CD94hi peak was undetectable on Klrc1–/–
NK cells, indicating that NK cells express CD94/NKG2X com-
plexes exclusively in the form of CD94/NKG2A heterodimers.
CD8+ T cells in both WT and Klrc1–/– mice expressed similar
amounts of CD94 after ECTV infection. However, Klrc1–/– CD8+
T cells expressed CD94 overwhelmingly without NKG2X proteins
(Figure 1C, bottom, and 1B). Our CD94 expression analysis
therefore demonstrates that althoughmouse CD94 preferentially
associates with NKG2A, it is expressed in lower amounts
(CD94lo) in the absence of NKG2A. Coupled with the lack of
NKG2C and NKG2E expression in the mouse, this indicates
that CD94 might also function as part of a yet-to-be-character-
ized receptor complex.
A recent study has shown that mouse CD94 contains a
charged transmembrane residue capable of associating directly
with the adaptors DAP10 and DAP12 (Saether et al., 2011). We
therefore sought to test whether CD94loNKG2X– NK cells
required DAP10 (encoded by Hcst) or DAP12 (encoded by
Tyrobp) for surface expression of CD94. We found that the
CD94lo population was markedly reduced in Tyrobp–/– NK cells,
whereas it was maintained in Hcst–/– NK cells (Figure 1D). For
controls, we confirmed that Ly49H expression was largely abla-
ted in Tyrobp–/– NK cells and that NKG2X expression was main-
tained (Figure 1E). This indicates that in mouse NK cells, CD94
itself might function as aDAP12-associated activating NK recep-
tor. Because activated CD8+ T cells express DAP10 but not
DAP12, we also asked whether CD94/NKG2A heterodimers
require DAP10 for surface expression. As expected, we found
that expression of this heterodimer was maintained on Hcst–/–
nonspecific and antigen-specific CD8+ T cells (Figure 1F). It is
likely that in the absence of NKG2A, CD94 surface expression re-
quires DAP10, although a formal demonstration requires the
generation of Klrc1–/– 3 Hcst–/– mice. Taken together, these
data indicate that two CD94 complexes are found on the surfaceunity 43, 1112–1124, December 15, 2015 ª2015 Elsevier Inc. 1113
Figure 1. NK and CD8+ T Cells Do Not Express NKG2C or NKG2E on the Cell Surface
(A and B) Spleens were analyzed by flow cytometry for surface expression of NKG2ACE and CD94 under naive conditions or 7 dpi of f.p. with 1,000 PFU ECTV-
Moscow. NK cells (A) and CD8+ T cells (B) are depicted.
(C) CD94 expression was measured on splenic NK cells (top) and CD8+ T cells (bottom). Both histograms depict naive WT cells (black dashed line), naive Klrc1–/–
cells (red dashed line), ECTV-stimulated WT cells (black solid line), ECTV-stimulated Klrc1–/– cells (red solid line). Cells stained with isotype control antibodies fell
within black bars.
(D) Naive splenic NK cells from WT, Hcst–/–, and Tyrobp–/– mice were assessed for CD94lo and CD94hi populations.
(E) Ly49H, NKG2ACE, and CD94 expression was assessed on WT and Tyrobp–/– naive splenic NK cells.
(F) NKG2ACE and CD94 expression was measured on total CD8+ T cells from WT and Hcst–/– mice. Mice were infected with LCMV clone 13 and on day 8 p.i.,
spleens were isolated.
(G) Schematic of NKG2A and CD94 surface expression on mouse killer cells. Data are representative of at least three independent experiments.
Further supporting evidence can be found in Figure S1 and Table S1.of mouse killer cells: one containing NKG2A and another that
lacks a Klrc-encoded partner (Figure 1G).
NKG2A Is Important for the Control of ECTV Infection
Because a previous study indicated that an intact CD94-depen-
dent NK cell response is required to resist infection to ECTV
(Fang et al., 2011) and we were unable to detect expression of
either NKG2C or NKG2E on NK cells, we hypothesized that
NKG2A might play an important role in controlling this infection.
Therefore, we challenged Klrc1–/– mice with a standard 1,000
PFU dose of ECTV in the footpad and observed that Klrc1–/–1114 Immunity 43, 1112–1124, December 15, 2015 ª2015 Elsevier Inmale mice were very susceptible to this infection, evident by
increased morbidity and mortality (Figures 2A and 2B) as well
as elevated viremia and splenic viral loads 6–10 days after infec-
tion (Figure 2C). Klrc1–/– female mice also had higher viremia and
splenic viral loads than did WT female mice, although morbidity
and mortality were similar. It has been shown that males are
more vulnerable than females in mouse strains susceptible to
ECTV (Brownstein and Gras, 1995). Here, we also noted that
males, in general, had higher viremia and liver titers than their fe-
male counterparts (Figure 2C). Thus, the severe susceptibility of
the Klrc1–/–males appears to be a combination of a general malec.
Figure 2. Klrc1–/– Mice Are More Susceptible to ECTV Infection
(A and B) WT and Klrc1–/– mice were infected with ECTV and monitored for survival (A) and body weight (B) over time.
(C) Viral load was assessed at 6 dpi. ECTV genome load in the blood was measured by quantitative RT-PCR. Spleen and liver viral loads were determined by
plaque assay. Black bars indicate WT tissues and white bars indicate Klrc1–/– tissues.
(D) WT (black circles) and Klrc1–/– (white circles) blood was collected from ECTV-infected animals 6 dpi and was assessed by complete white blood cell (WBC)
counts and WBC differentials (segmented neutrophil, lymphocyte, and platelet counts).
(E and F) WT (E) and Klrc1–/– (F) spleens were fixed and stained with H&E 6 dpi. Original magnification 403. Scale bars represent 20 mm.
(G) Total splenocyte and splenic leukocyte cell numbers were assessed 7 dpi.
(H) Neutrophil (CD11b+Ly6C+Ly6G+) and monocyte (CD11b+Ly6C+Ly6G–) frequencies and cell numbers were assessed 7 dpi.
Images in (E) and (F) are representative of two independent experiments. All other data were pooled from at least two independent experiments and were
analyzed by multiple t tests. Mean ± SEM is represented on relevant graphs. Further supporting evidence can be found in Figure S2 and Table S1.vulnerability to ECTV coupled with a bona fide role for NKG2A in
the anti-ECTV response.
We next assessed the blood for any disruptions in cellularity. At
7 days after infection, we noted significant increases in total white
blood cell (WBC) counts, specifically in the number of neutrophils
and lymphocytes, concomitant with a corresponding reduction in
the number of platelets per volume of blood in Klrc1–/– mice (Fig-
ure 2D). Marked histopathology was also evident in hematoxylin
and eosin (H&E) staining of spleen sections from Klrc1–/– mice,
which were highly acellular with disrupted tissue architecture
compared to WT controls 7 days after infection (Figures 2E and
2F). The acellularity of Klrc1–/– spleens was attributable to reduc-
tion in multiple leukocyte populations, including NK cells, T cells,
B cells, dendritic cells, and macrophages (Figure 2G). NeutrophilImmand monocyte frequencies, however, were relatively increased
and numbers were largely maintained in Klrc1–/– spleens, indi-
cating that any perturbation due to the anti-viral response also re-
sulted in accrual of neutrophils and monocytes (Figure 2H). In
contrast, livers, lungs, and kidneys from Klrc1–/– mice appeared
to remain largely intact and comparable to WT tissues after
ECTV infection (datanot shown). Therefore,ECTV infectioncauses
pathology preferentially in the spleen and blood of Klrc1–/– mice.
Klrc1–/–Mice Harbor an Otherwise Intact Klrc Locus and
Susceptibility to ECTV Segregates with the Targeted
Mutation of Klrc1
We wanted to ensure that these results were wholly attributable
to elimination of NKG2A expression and not to more drasticunity 43, 1112–1124, December 15, 2015 ª2015 Elsevier Inc. 1115
disruption of the Klrc locus, possibly engendered during target-
ing. Therefore we sequenced the entire Klrc locus to confirm that
it remained intact (apart from the targeted deletion ofKlrc1) in the
Klrc1–/– mice. The only mutations found within the Klrc1–/– line
were an approximately 2.5 kb deletion corresponding to the tar-
geted deletion of Klrc1 and few surrounding point mutations that
were probably introduced during PCR amplification of the ho-
mology arms of the targeting construct (Table S1). Furthermore,
as mentioned previously, Klrc2 and Klrc3 transcripts were pre-
sent at similar levels in the spleens of both WT and Klrc1–/–
mice (Figure S1B), indicating that the deletion and point muta-
tions did not disrupt transcriptional regulation of the Klrc locus.
Also, as noted in Figure 1, CD94 expression was equivalent to
WT in the Klrc1–/– line. Because Klrc2, Klrc3, and Klrd1 are the
genes nearest to the targeted region, their unaltered expression
indicates that the targeted deletion of Klrc1 is specific and that
the Klrc1–/– strain contains an otherwise intact Klrc locus.
To rule out the possibility that the targeted ES clone used to
generate the mice contained other chromosomal mutations,
particularly on the Y chromosome, that might be responsible
for the ECTV phenotype, we bred male and female Klrc1–/–
mice to C57BL/6 WT mice to generate heterozygotes; these
were intercrossed to generate two groups of Klrc1–/–, Klrc1–/+,
and Klrc1+/+ F2 mice, one with the Y chromosome from
Klrc1–/– males and the other with the Y chromosome from
C57BL/6 males. The Klrc1–/– males from both groups of F2
mice were acutely susceptible to ECTV (Figures S2A–S2C),
corroborating our initial observation that increased susceptibility
to ECTV segregates with and is due to the targeted Klrc1
mutation.
NKG2ADeficiency Results in Fewer ECTV-SpecificCD8+
T Cells that Exhibit Increased Effector Functionality
Given that mice die at 8–10 days after ECTV infection and that
NK cells and CD8+ T cells predominate anti-ECTV responses
at this stage (Parker et al., 2007) and express NKG2A, we evalu-
ated the impact of NKG2A deficiency on CD8+ T cell and NK cell
responses. The number of Klrc1–/–-specific CD8+ T cells was
markedly reduced after ECTV infection, as judged by B8R20-27-
H2-Kb tetramer staining, indicating that NKG2A might function
to enhance the accumulation of specific CD8+ T cells (Figure 3A).
In contrast, Klrc1–/– CD8+ T cells restimulated ex vivo with the
immunodominant epitope of the orthopoxvirus B8R protein
(B8R20-27) had more intracellular IFN-g than did WT cells and ex-
pressed more CD107a, a marker of degranulation (Figure 3B).
This indicates that, on a per cell basis, NKG2A inhibits effector
functions of virus-specific CD8+ T cells. In agreement, Klrc1–/–
CD8+ T cells secreted greater quantities of IFN-g when stimu-
lated with B8R20-27 (Figure 3C). We also detected significantly
higher quantities of IFN-g in the sera of Klrc1–/– males at 7 dpi
(Figure 3D). These data indicate that NKG2A might function to
both limit CD8+ T cell activation and sustain the specific CD8+
T cell population in the context of ECTV infection.
Given the increased quantities of IFN-g found in Klrc1–/–mice,
we next asked whether NKG2A deficiency resulted in greater
production of other cytokines by CD8+ T cells. Notably, we
found that more granulocyte-monocyte colony stimulating factor
(GM-CSF), but not tumor necrosis factor (TNF) or interleukin-2
(IL-2), was produced by virus-specific Klrc1–/– CD8+ T cells—1116 Immunity 43, 1112–1124, December 15, 2015 ª2015 Elsevier Inthe same T cells that produced high amounts of IFN-g (Figures
3E–3G). GM-CSF promotes myeloid cell accrual, so these
data suggest that during ECTV infection, NKG2A deficiency
results specifically in polyfunctional IFN-ghiGM-CSF+CD8+
T cells that could contribute to the neutrophil and monocyte
accumulation seen in Klrc1–/– spleens. Moreover, Klrc1–/– CD8+
T cells were generally larger and more granular than their
WT counterparts at 7 dpi, but did not exhibit altered skewing
toward a short-lived effector cell (SLEC) population or memory
precursor effector cell (MPEC) (Figures 3H and 3I), suggesting
that NKG2A limits general activation of ECTV-specific CD8+
T cells.
Klrc1–/– NK Cells Remain Functionally Intact after ECTV
Infection
We assessed NK cell function in the spleen at 5.5 dpi, when
NKG2AexpressiononCD8+T cell control appears tobe important
for viral control. WT and Klrc1–/–NK cells restimulated in vitro with
tumor target cells expressed equivalent levels of both IFN-g and
CD107a, indicating that NK cell function is largely maintained in
the absence of NKG2A (Figure 3J). To determine whether
Klrc1–/– NK cell function was altered at earlier time points, when
CD8+ T cells were not yet primed, we quantified the viral burden
in draining popliteal lymph nodes 3 days after footpad infection
with ECTV (Figure 3K). We chose this time point because early
resistance to ECTV is more dependent on NK cells and popliteal
lymph nodes are the primary location for viral replication prior to
systemic infection (Parker et al., 2007). However, therewas nodif-
ference in viral burden in the popliteal lymph nodes at this time,
suggesting that NKG2A plays an insignificant role in early NK
cell-mediated control of ECTV infection. Thus, NKG2Aexpression
on NK cells has no effect on the control of ECTV infection.
Klrc1–/– Thymocytes Develop Normally and NKG2A
Marks a Population of Thymic NKT Cells
Given that NKG2A deficiency resulted in a reduced number of
antiviral CD8+ T cells, we sought to further assess the role of
NKG2A in T cell development by analyzing thymuses of WT
and Klrc1–/– mice. However, we found no differences in any
thymocyte subset in Klrc1–/– mice (Figure S3A). We did observe
that subsets of both CD4CD8 and CD4 single-positive cells
express NKG2A (Figure S3B). We found that these cells were
thymic NKT cells, as judged by co-expression of NK1.1 and
CD3 and the fact that NKG2A deficiency did not alter the accu-
mulation of these cells in the thymus (Figure S3C). Together,
these data show that NKG2A is not expressed on thymocytes
and does not alter thymocyte development, but does mark a
population of thymic NKT cells.
Klrc1–/– ECTV-Specific CD8+ T Cells Express Genes
Associated with Lymphocyte Activation and Apoptosis
Given that NKG2A deficiency leads to excessive effector func-
tions of CD8+ T cells after ECTV infection, we sought to analyze
whether NKG2A signaling altered specific transcriptional path-
ways associated with T cell activation. To test this, we sorted
both naive and ECTV-specific CD8+ T cells and analyzed the
transcriptomes via microarray analysis. WT and Klrc1–/– CD8+
T cell transcriptomes were broadly similar when assessed by
principal component analysis (PCA) (Figure 4A). There werec.
Figure 3. Characterization of WT and Klrc1–/– CD8+ T Cell and NK Cell Responses to ECTV
Mice were infected with ECTV and spleens analyzed for CD8+ T cell responses 7 dpi.
(A) CD3+CD8+B8R-H2-Kb+ T cell numbers were quantified in spleens.
(B) WT or Klrc1–/– splenocytes were pulsed ex vivo with irrelevant SIINFEKL peptide or poxvirus-specific B8R20-27, then assessed for CD107a and IFN-g
expression by intracellular staining of CD3+CD8+ lymphocytes. The frequency of CD107a+IFN-g+CD8+ T cells andMFI of IFN-g+ cells were quantified inWT (black
bars) and Klrc1–/– (white bars) splenocytes.
(C) Splenocytes were incubated overnight with irrelevant or B8R20-27 peptides to restimulate CD8
+ T cells. IFN-g accumulation in the supernatant was quantified
by bead array.
(D) IFN-g concentration was measured from the sera of ECTV-infected mice by bead array.
(E) Splenocytes were treated as in (A), then assessed for GM-CSF intracellular content. GM-CSF+ cell frequency and MFI of GM-CSF+ cells are shown.
(F) Splenocytes were treated as in (C). GM-CSF accumulation in the supernatant was quantified by ELISA.
(G) Splenocytes were treated as in (A), and TNF or IL-2 intracellular content was determined.
(H) CD3+CD8+ lymphocyte blasting was assessed by FSC and SSC.
(I) Total CD3+CD8+ lymphocytes were analyzed for KLRG1 and CD127 expression. Frequency of SLEC (KLRG1+CD127) and MPEC (KLRG1CD127+) pop-
ulations are shown.
(J) Expression of IFN-g and CD107a in splenic NK cells were measured 5.5 dpi. Splenocytes were incubated with or without 1 3 105 YAC-1 targets cells, then
stained for NK cell markers and intracellular IFN-g. Dot plots show CD107a and IFN-g expression on CD3NK1.1+ NK cells.
(K) Viral load in popliteal lymph nodes was assessed by plaque assay 3 dpi.
All data are pooled from at least two independent experiments and were analyzed by multiple t tests. Mean ± SEM is represented on relevant graphs. Further
supporting evidence can be found in Figure S3.onlymild variations in individual gene expression profiles of naive
CD8+ T cells (Figure 4B). However, there were wider variations in
the expression of 225 transcripts by ECTV-specific WT and
Klrc1–/– CD8+ T cells (Figures 4C and 4D), which associatedImmwith specific pathways as judged by gene ontology pathway
analysis (Figure 4E). Klrc1–/– cells contained an overabundance
of transcripts falling within five categories of stimulatory path-
ways, including responses to stress and stimuli, cell proliferation,unity 43, 1112–1124, December 15, 2015 ª2015 Elsevier Inc. 1117
Figure 4. Differential Expression of Genes Associated with Lymphocyte Activation in Klrc1–/– ECTV-Specific CD8+ T Cells
CD3+CD8+B8R-H2-Kb+ T cells were sorted fromWT and Klrc1–/– mice infected with ECTV and total RNA was isolated. As a control, RNA was isolated from total
CD3+CD8+ T cells of naive WT and Klrc1–/– mice. Transcriptomes of all RNA samples were assessed by microarray analysis.
(A) Principal component analysis of total naive and ECTV-specific CD8+ T cells. Naive WT (blue dots), naive Klrc1–/– (green dots), WT infected (purple dots), and
Klrc1–/– infected (orange dots) samples are shown.
(B and C) Volcano plots of naive WT versus naive Klrc1–/– CD8+ T cells (B) or ECTV-specific WT versus ECTV-specific Klrc1–/– CD8+ T cells (C). Transcripts
differentially expressed in Klrc1–/– cells (blue dots) versus WT cells (red dots) are labeled. Klrc1 is also indicated in both plots.
(D) Heatmap of all genes differentially expressed betweenWT andKlrc1–/–CD8+ T cells. The scale ranges fromminimum (green boxes) tomedium (black boxes) to
maximum (red boxes) relative expression.
(E) Gene ontology pathway analysis of ECTV-specific CD8+ T cells. Red bars indicate pathways overrepresented in WT cells and blue bars indicate pathways
overrepresented in Klrc1–/– cells.
(F) Heatmap of genes representative of the differentially expressed pathways depicted in (E). Coloration is equivalent to that used in (D).
(G) Quantitative RT-PCR amplification of relevant genes to validate microarray analysis data. All transcripts are shown relative to Gapdh copy number.
Mean ± SEM is represented on relevant graphs.and lymphocyte activation. Several individual transcripts over-
abundant in Klrc1–/– cells were indicative of CD8+ T cell activa-
tion, including Ifng, Prf1, Rel, Batf3, and Bhlhe40 (Figure 4F).
Upregulation of Bhlhe40 most likely explains the augmented
production of GM-CSF by virus-specific Klrc1–/– CD8+ T cells,
because Bhlhe40 positively regulates the production of GM-CSF
(Lin et al., 2014). Importantly, Klrc1–/– cells also overexpressed
Bcl2l11, which encodes Bim, a key pro-apoptotic mediator. In
contrast, WT ECTV-specific CD8+ T cells featured an overabun-
dance of transcripts that fell within immunoregulatory pathways,
including Il10, Il10r, Smad3, and Tnfaip3 (Figure 4F). Differential1118 Immunity 43, 1112–1124, December 15, 2015 ª2015 Elsevier Inexpression of relevant genes was further verified by quantitative
real-time PCR analysis of ECTV-specific CD8+ T cell cDNA
(Figure 4G). Overall, transcriptional changes in Klrc1–/– ECTV-
specific CD8+ T cells indicate that these cells are more activated
than their WT counterparts and are potentially more susceptible
to apoptosis.
Klrc1–/–-Specific CD8+ T Cells Are Intrinsically
Vulnerable to Apoptosis
Our previous data suggest that NKG2A limits effector functions
of ECTV-specific CD8+ T cells, while sustaining a higher numberc.
Figure 5. NKG2A Limits Apoptosis of Virus-Specific CD8+ T Cells in a Cell-Intrinsic Manner
(A) Schematic to test for a cell-intrinsic mechanism of NKG2A function in ECTV-specific CD8+ T cell survival.
(B) WT and Klrc1–/– male mice were infected f.p. with either 7,000 PFU ECTV-WT or 9,000 PFU EV/NP-S-GFP and survival was monitored for 7.5 weeks after
infection.
(C) WTCD45.1 and Klrc1–/–mice were immunized with 5,000 PFU ECTV-ova f.p. and CD8+ T cells were enriched from spleens 7 dpi via MACS selection. Cells were
then mixed at a 1:1 ratio of B8R-H2-Kb+ cells and adoptively transferred into Rag1–/– hosts.
(D) Rag1–/– hosts were either left uninfected or infected with ECTV-WT for 7 days, then analyzed for B8R-H2-Kb+ CD8+ T cells.
(E) Frequencies of WT and Klrc1–/–CD3+CD8+B8R-H2-Kb+ cells fromRag1–/– spleens 7 dpi with ECTV-WT. Total CD3+CD8+B8R-H2-Kb+ cell numbers from naive
or ECTV-WT-infected Rag1–/– spleens are shown on the right.
(F) Schematic to test for a cell-extrinsic mechanism of NKG2A function in ECTV-specific CD8+ T cells.
(G) Total number of specific donor cells (CD45.1+CD3+CD8+B8R-H2-Kb+ cells) isolated from naive hosts or ECTV-WT-infected hosts.
(H) Mice were treated with either control or NK-cell-depleting antibody prior to infection with 200 PFU ECTV-WT. On days 6 or 8 post-infection, spleens were
isolated and antigen-specific CD8+ T cell numbers were quantified.
(I) WT and Klrc1–/– splenocytes were isolated 7 days after ECTV infection and put in culture in the presence or absence of plate-bound anti-CD3 antibody. After
2 days, CD8+ T cells were assessed for Annexin V (left) and 7AAD (right).
(J) Cells were prepared as in (I) and CD4+ T cells were analyzed.
(legend continued on next page)
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of specific CD8+ T cells. These data, combined with the over-
abundance of Bcl2l11 transcript in Klrc1–/–-specific CD8+
T cells, led us to hypothesize that NKG2A has two distinct func-
tions within CD8+ T cells: to limit excessive effector function and
to prevent unnecessary apoptosis. To test this in vivo, we de-
signed an adoptive transfer system that would allow us to
observe Klrc1–/– B8R-specific CD8+ T cells in competition with
WT B8R-specific CD8+ T cells during ECTV infection (Figure 5A).
To generate a pool of B8R-specific T cells, CD45.1 WTmice and
CD45.2 Klrc1–/– mice were infected with an ova peptide-trans-
genic strain of ECTV (EV/NP-S-GFP) that causes less mortality
inKlrc1–/–mice (Figure 5B). Approximately 1 week after infection,
splenic CD8+ T cells from each strain were enriched and as-
sessed for TCR specificity by staining with B8R-H2-Kb tetra-
mers, and then mixed at a 1:1 ratio of tetramer+ cells (Figure 5C).
This mixture was injected i.v. into Rag1–/– hosts, which were in-
fected with WT-ECTV 1 day after transfer. As a control, some
Rag1–/– mice were given the T cell mixture, but not infected
with virus. Uninfected Rag1–/– spleens did not harbor a signifi-
cant population of specific T cells 8 days after transfer. Hosts
that were infectedwithWT virus, however, had a noticeable pop-
ulation of B8R-specific CD8+ T cells (Figure 5D). In the infected
hosts, WT (CD45.1)-specific donor cells were more frequent
and significantly outnumbered Klrc1–/– (CD45.2) donor cells (Fig-
ure 5E). This result establishes an in vivo, cell-intrinsic role for
NKG2A on antigen-specific CD8+ T cells in response to ECTV.
NKG2A Deficiency Does Not Affect Virus-Specific CD8+
T Cells in a Cell-Extrinsic Manner
Although Klrc1–/– CD8+ T cells are intrinsically less stable than
their WT counterparts after ECTV infection, it remained possible
that T-cell-extrinsic mechanisms, such as NK-cell-mediated
killing of DCs or T cells, might also contribute to the dysfunctional
CD8+ T cell response in Klrc1–/–mice. To determine whether any
other NKG2A-expressing cell affects the CD8+ T cell response
in vivo, we designed another adoptive transfer experiment that
would allow us to observe how donor WT B8R-specific CD8+
T cells survived in either a WT or Klrc1–/– host environment after
ECTV infection (Figure 5F). CD45.1 WT B8R-specific CD8+
T cells survived equally well in both WT and Klrc1–/– CD45.2
hosts, as judged by the number of B8R-H2-Kb+CD45.1+ donor
cells present in host spleens 7 dpi with WT-ECTV (Figure 5G).
Finally, several reports have indicated that NK cells are capable
of killing virus-specific T cells or otherwise impeding their prim-
ing (Andrews et al., 2010; Crouse et al., 2014; Lu et al., 2007;
Schuster et al., 2014; Waggoner et al., 2010, 2012; Xu et al.,
2014). We therefore depleted NK cells prior to ECTV infection
to assess whether CD8+ T cell numbers could be restored in
the absence of NK cells. However, we found that antigen-spe-
cific CD8+ T cells were highly reduced in both WT and Klrc1–/–
spleens after NK cell depletion, indicating that NK cells probably
function to control ECTV early enough to allow for the priming of
an adequate CD8+ T cell response (Figure 5H). Combined, this
indicates that NKG2A expression on any cell other than the(K) WT and Klrc1–/– splenocytes were isolated 7 days after ECTV infection and c
culture, numbers of CD8+B8R-H2-Kb+ cells were quantified (left) and assessed f
All panels depict WT cells (filled circles/bars) and Klrc1–/– cells (open circles/bars)
analyzed by multiple t tests. Mean ± SEM is represented on relevant graphs.
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tional specific T cell response.
Klrc1–/– ECTV-Specific CD8+ T Cells Are More
Susceptible to Apoptosis
To test whether the excessive apoptosis of ECTV-specific
Klrc1–/–-specific CD8+ T cells was attributable directly to overac-
tivation, we restimulated splenocytes from ECTV-infected mice
ex vivo with increasing concentrations of plate-bound anti-CD3
antibody. After 2 days in culture with the plate-bound anti-
CD3, we could not detect staining with the B8R-H2-Kb tetramer,
suggesting that the CD8+ T cell population was highly activated
to the point of TCR downregulation (data not shown). Total CD8+
T cells of Klrc1–/– mice exhibited consistently higher Annexin V
and 7AAD staining compared to WT controls and overall were
more sensitive to apoptosis after CD3-induced activation (Fig-
ure 5I). In contrast, CD4+ T cells from both strains were equally
sensitive to CD3-induced apoptosis, indicating that enhanced
susceptibility was limited to Klrc1–/– CD8+ T cells (Figure 5J).
To determine whether Klrc1–/– ECTV-specific CD8+ T cells
were as susceptible to apoptosis as the total Klrc1–/– CD8+
T cell population, CD8+ T cell viability and apoptosis was deter-
mined after ex vivo stimulation with low amounts of IL-2, which
would not downregulate TCR expression. Antigen-specific
CD8+ T cell numbers and Annexin V binding were measured 1,
3, and 5 days after culture with IL-2. WT cell numbers increased
ex vivo, whereas Klrc1–/– cell numbers decreased over the same
time period (Figure 5K, left). The inverse was true of Annexin V
staining; fewer than 5% of WT cells were Annexin V+ by day 3,
but approximately 25% of the remaining Klrc1–/– cells were
beginning to undergo apoptosis (Figure 5K, right). These data
indicate that NKG2A can function specifically within activated
CD8+ T cells to modulate activation and prevent aberrant
apoptosis.
Qa-1 Is Preferentially Expressed on B Cells in ECTV-
Infected Tissues
Because NKG2A appears to function intrinsically within antigen-
specific CD8+ T cells, we reasoned that there must be an anti-
gen-presenting cell (APC) population within an ECTV-infected
secondary lymphoid tissue that expresses Qa-1 and can stimu-
late the CD8+ T cell response.We found that naive splenic B cells
expressed low, but detectable, amounts of Qa-1 and that B cells
in ECTV-infected spleens upregulate Qa-1 expression (Fig-
ure 6A). In both naive and infected spleens, B cells expressed
Qa-1 at higher amounts than non-B cells. Furthermore, when
we infected WT and Klrc1–/– mice with the ova peptide-trans-
genic strain of ECTV used for the adoptive transfer immuniza-
tions, B cells in popliteal lymph nodes at 3 dpi were activated
and presented the ova peptide, as detected by a SIINFEKL-
H2-Kb-specific antibody. Thus, B cells are capable of both prim-
ing CD8+ T cells and interacting with CD94/NKG2A heterodimers
(Figure 6B). A similar observation was made in spleens at 7 dpi,
with both WT and Klrc1–/– B cells presenting ECTV-derivedultured in complete RPMI containing 13 ng/ml rhIL-2. At 1, 3, and 5 days after
or Annexin V staining (right).
. All data are representative of at least two independent experiments and were
c.
Figure 6. Qa-1 Is Preferentially Expressed on ECTV-Activated B
Cells
(A) Splenocytes from naive or ECTV-infected mice were assessed for Qa-1
expression. Qa-1 MFI of CD19+ versus CD19 splenocytes is shown on the
left. Expression of Qa-1 on splenic B cells from naive or ECTV-infected mice is
shown on the right.
(B) CD19+ popliteal lymph nodes B cells were assessed for H2-Kb-SIINFEKL
and CD86 expression with specific antibodies 3 days after infection with EV/
NP-S-GFP.
(C) CD19+ splenic B cells were assessed H2-Kb-SIINFEKL and CD86
expression 7 days after infectionwith EV/NP-S-GFP or from uninfected naiveB
cells.
Data are representative of at least three independent experiments. Mean ±
SEM is represented on relevant graphs. Further supporting evidence can be
found in Figure S4.antigen and undergoing activation (Figure 6C). Given the relative
dominance of B cell numbers in the nodes and spleen, we hy-
pothesize that B cells are the dominant APCs responsible for
activating CD8+ T cells and interacting with CD94/NKG2A heter-
odimers after ECTV infection.
NKG2A Is Dispensable for Control of LCMV, VSV, and VV
Infections
ECTV is somewhat unusual among mouse models of viral infec-
tion in that it is a natural pathogen that is acutely lethal in many
murine strains at low infectious doses and hence requires
robust innate and adaptive responses, even for subcutaneous
infections of as little as 1,000 PFU of virus. We were therefore
interested in determining whether NKG2A is broadly necessary
for combating viral infections and, furthermore, how differentImmviruses would affect the CD8+ T cell response in the absence
of NKG2A. To do this, we chose to infect WT and Klrc1–/– mice
with nonlethal viruses that cause either acute (VSV-ova) or
chronic (LCMV clone 13) infection in C57BL/6 mice, as well as
with VV, an attenuated orthopoxvirus that is highly homologous
to ECTV. VSV-ova splenic viral loads were similar in Klrc1–/–
andWTmice 8 hr after infection (Figure S4A). At 7 dpi, after repli-
cating virus was cleared from C57BL/6 mice, the specific CD8+
T cell response in Klrc1–/– spleens was similar to WT controls,
as judged by ova-H2-Kb-tetramer staining (Figure S4B). At 15
dpi with LCMV clone 13, viral loads in spleen, liver, kidney, and
lung were all equivalent in Klrc1–/– and WT C57BL/6 mice (Fig-
ure S4C). After infection with VV, WT and Klrc1–/– mice lost little
or no weight (Figure S4D) and had equivalent frequencies of spe-
cific and total CD8+ T cells in spleens and draining lymph nodes
(Figures S4E and S4F). Together, these data indicate that
NKG2Amight be necessary in antigen-activated T cells only dur-
ing acute infections by highly replicative and cytopathic viruses,
or perhaps specifically during ECTV infection.
DISCUSSION
In this study we have shown that Klrc1–/– mice are highly suscep-
tible to infection by the mouse natural pathogen ECTV due to
a defect in virus-specific CD8+ T cell responses. This defect
is cell intrinsic, as NKG2A expression is required to prevent
excessive activation and AICD of virus-specific CD8+ T cells. It
is noteworthy that NKG2A is essential for host survival after
ECTV infection but is not required for responses to an attenuated
poxvirus, VV, or other viruses tested in our study, including VSV
and LCMV. This result suggests that evolution of the Klrc locus
might have been driven by pressure imposed by deadly poxvirus
infections that cause excessive stimulation of CD8+ T cells.
One previous study found that CD94-deficient (Klrd1–/–) mice
are also highly susceptible to ECTV infection (Fang et al.,
2011). However, susceptibility was associated with defective
expression and function of NKG2E on NK cells. Our analysis of
WT and Klrc1–/– mice revealed essentially no expression of
NKG2C or NKG2E on NK cells, which is consistent with several
other studies (Kawamura et al., 2009; Vance et al., 1999,
2002). Moreover, if undetected CD94/NKG2E heterodimers
could mediate ECTV clearance, we would expect Klrc1–/– mice
to be more resistant to ECTV infection than WT mice, because
CD94/NKG2E-mediated activation would not be countered by
NKG2A-mediated inhibition. Thus, susceptibility of Klrd1–/–
mice to ECTV seems most likely due to lack of CD94/NKG2A
heterodimers rather than lack of CD94/NKG2E heterodimers.
However, because Klrd1–/– mice were generated on the 129
background and backcrossed onto C57BL/6 mice (Fang et al.,
2011), it is also possible that the Klrc locus remained 129 in these
mice and that the activating isoforms of NKG2X are expressed
and functional in this background. Whatever the case, both
studies highlight the importance of the Klrc locus in the control
of acute poxvirus infections.
It is clear from our data that impaired CD8+ T cell responses in
ECTV-infected Klrc1–/– mice are due to a T-cell-intrinsic rather
than a T-cell-extrinsic defect. Why does lack of NKG2A have a
dramatic effect during acute ECTV infection but no impact on
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might be essential during anti-ECTV responses because ECTV is
a natural pathogen that is highly replicative and might provoke
extreme antigenic stimulation of CD8+ T cells. ECTV is also highly
cytopathic and aggressively infects secondary lymphoid tissues,
such as the spleen and popliteal lymph nodes, disrupting their
architecture (Esteban and Buller, 2005). This could attenuate
initial T cell priming and further stress the relatively few virus-
specific T cells that need to control infection in a highly inflamma-
tory environment. In this scenario, the lack of NKG2A, which
restrains overactivation, might have catastrophic effects.
It is also possible that during non-ECTV infections other inhib-
itory receptor-ligand interactions contribute more than NKG2A
to finely tune CD8+ T cell activation. This has been demonstrated
during chronic LCMV infection, in which the absence of the inhib-
itory receptor 2B4 results in a suboptimal T cell response and
exacerbated chronic disease (Waggoner et al., 2010). Although
it was recently shown that T cells express Qa-1 during chronic
LCMV infection, perhaps protecting them from NK-cell-medi-
ated lysis by engaging CD94/NKG2A heterodimers (Xu et al.,
2014), in our study, lack of NKG2A did not impact the course
of chronic LCMV infection. NKG2A was also dispensable for
sustaining specific CD8+ T cells during influenza virus and
adenovirus infections, but did limit immunopathology (Ely et al.,
2014). Thus, we postulate that NKG2Amight have various effects
during different viral infections. These effects include preventing
extreme activation and AICD (ECTV infection); limiting effector
responses and immunopathology (influenza and adenovirus);
no detectable impact due to the contribution of other inhibitory
interactions (LCMV); and perhaps exhaustion and reduced con-
trol of viral replication (chronic infections yet to be identified).
During ECTV infection, all cells expressing Qa-1 can deliver
an inhibitory signal to NKG2A+CD8+ T cells that prevents
AICD. However, we noticed that B cells express Qa-1 at higher
amounts than non-B cells in both naive and infected spleens.
Furthermore, we demonstrated that B cells are infected by
ECTV and present viral peptides, which has been corroborated
by a recent study (Sei et al., 2015). Thus, B cells might be
the dominant APCs that activate CD8+ T cells and interact
with CD94/NKG2A heterodimers during ECTV infection. Upon
engagement, CD94/NKG2A heterodimers most likely optimize
CD8+ T cell activation through recruitment of SHP-1 and inhibi-
tion of tyrosine kinases, thereby preventing AICD. A similar
mechanism was previously proposed for the ability of the human
inhibitory receptor KIR2DL3 to attenuate AICD of memory CD8+
T cells in response to peptide stimulation in vitro (Ugolini et al.,
2001). Additionally, since the TCR co-receptor CD8 can bind to
Qa-1, CD94/NKG2A heterodimers might be crucial for outcom-
peting CD8 binding and limiting CD8-mediated costimulation
after initial T cell priming.
This study reshapes our understanding of surface expression
of the Klrc locus-encoded receptors in mice. We demonstrate
that mouse NKG2C and NKG2E are not expressed on the cell
surface, at least in the B6 background. CD94 is mainly associ-
ated with NKG2A in CD94hi NK cells and CD94hi activated
CD8+ T cells. However, CD94 remains expressed on CD94lo
NK cells in the absence of NKG2X as part of a complex with
DAP12. Activated CD8+ T cells express DAP10 but not DAP12,
so it is likely CD94 pairs with DAP10 in activated CD8+ T cells
that lack NKG2X, although this conclusion should be conclu-1122 Immunity 43, 1112–1124, December 15, 2015 ª2015 Elsevier Insively confirmed through the generation of Klrc1–/– 3 Hcst–/–
mice. These results are in agreement with a previous demonstra-
tion that mouse CD94 directly associates with DAP12 and
DAP10 through a salt bridge in the transmembrane region
without requiring NKG2C or NKG2E (Saether et al., 2011).
Further studies will be essential to define the function of CD94/
DAP12 and CD94/DAP10 complexes.
EXPERIMENTAL PROCEDURES
Mice
Klrc1–/– (Figure S1), WT C57BL/6J, Hcst–/–, and B6.Rag1–/– mice were housed
in specific-pathogen-free conditions at Washington University in St. Louis and
St. Louis University. B6.SJL-Ptprca Pepcb/BoyJ mice (CD45.1+ C57BL/6
strain) were purchased from Jackson Laboratory and subsequently bred
in-house. Tyrobp–/– mice were generated by Toshiyuki Takai (Tohoku Univer-
sity). All animal studies were approved by the animal studies committees at
Washington University School of Medicine in St. Louis and St. Louis University.
Experiments were performed according to the animal care guidelines of the
two institutions.
Viruses and Viral Infections
Plaque-purified ECTV (Moscow strain) was propagated on BS-C-1 cells. EV/
NP-S-GFP contains a FluNP-SIINFEKL-GFP cassette in the disrupted V region
(CrmC) of ECTV-Moscow (Parker et al., 2007). All ECTV and EV/NP-S-GFP in-
fections were done in the foot pad (f.p.). at the indicated doses. ECTV viremia
was assessed by quantitative real-time PCR of the EV107 gene. 5 3 106 PFU
Indiana strain VSV-ova was injected intravenously (i.v.). LCMV clone 13 was
administered i.v. at 2 3 106 PFU per mouse. Mice were infected in the f.p.
with 1.25 3 107 PFU vaccinia SIINFEKL GFP virus (virus was provided by
Dr. John Yewdell, NIAID). Viral loads were assessed from various tissues by
standard plaque assays on BS-C-1 (for ECTV) or Vero (for VSV-ova, LCMV
clone 13) cell monolayers.
Flow Cytometry
Antibodies, reagents, and staining methods can be found in the Supplemental
Experimental Procedures. All samples were run on either a BD FACSCalibur or
BD FACS Canto II system and analyzed with FlowJo software (Tree Star).
T Cell Restimulation Assay
Splenocytes from ECTV-infected mice were incubated overnight at 37C in
complete RPMI with either irrelevant peptide (SIINFEKL) or the poxvirus immu-
nodominant peptide B8R (TSYKFESV). Supernatants were collected and
IFN-g concentration was measured with the Mouse Inflammation CBA kit
(BD Biosciences). GM-CSF concentration was measured with Mouse
GM-CSF ELISA Ready-SET-Go! (eBioscience). For intracellular detection of
cytokines, cells were incubated for 6 hr in the presence of peptide and both
brefeldin A (BD Biosciences) and monensin (eBioscience), then stained as
described in the Supplemental Experimental Procedures.
RNA Isolation, Microarray, and Real-Time PCR Analysis
Cells were directly sorted into Buffer RLT Plus and RNA was isolated with the
RNeasy Plus Micro kit (QIAGEN). All RNA samples were then processed and
hybridized to Mouse Gene 1.0 ST arrays (Affymetrix) by Washington Univer-
sity’s Genome Technology Access Center. Detailed information on microarray
procedures and analysis can be found in the Supplemental Experimental
Procedures. cDNA was synthesized with a SuperScript first-strand synthesis
system (Invitrogen). Real-time quantitative PCR reactions were setup with iQ
SYBR Green Supermix (Bio-Rad) and specific primers (see Supplemental
Experimental Procedures) and run on a Bio-Rad iCycler.
T Cell Apoptosis Assay
Splenocytes from ECTV-infected mice were put into 96-well plates (2 3 106
cells/well) with complete RPMI supplemented with 13 ng/ml recombinant
human IL-2 (Peprotech). 1, 3, and 5 days later, cells were stained with Annexin
V and 7-AAD (PE Annexin V Apoptosis Detection Kit, BD PharMingen). B8R-
H2-Kb-APC tetramers and anti-CD8-FITC antibody were added to the stainingc.
cocktail to mark specific CD8+ T cells. Cells were then analyzed by flow cy-
tometry. In some experiments, splenocytes from ECTV-infected mice were
cultured on plates coated with or without purified anti-CD3ε. After 2 days, cells
were analyzed for the same apoptosis markers on either total CD8+ or CD4+
T cells.
Statistics
A Student’s t test or multiple t tests were performed in Prism (GraphPad) in all
cases. Mean ± SEM is represented on relevant graphs. *p < 0.05; **p < 0.01;
***p < 0.001; ****p < 0.0001.
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